Related Experiment Video
Updated: Mar 20, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
Insights
This review aids clinicians in diagnosing and treating pediatric acquired demyelinating syndromes. It details specific features and offers a general approach for evaluating these neurological disorders in children.
Area of Science:
- Pediatric Neurology
- Neuroimmunology
- Demyelinating Disorders
Background:
- Acquired demyelinating syndromes in children require precise diagnostic and therapeutic strategies.
- Understanding the expanding phenotype of these conditions is crucial for effective management.
Observation:
- Consensus definitions have improved recognition and understanding of pediatric acquired demyelinating syndromes.
- Clinical and radiologic features, prognosis, and treatment responses are increasingly well-characterized.
- Case studies illustrate the diverse presentations of these syndromes.
Findings:
- This review provides a structured approach to the evaluation of pediatric demyelination.
- It highlights key diagnostic features and treatment considerations for acquired demyelinating syndromes.
- Emerging therapies for chronic demyelinating disorders like multiple sclerosis and neuromyelitis optica spectrum disorder require further investigation.
Implications:
- Clinicians can better identify and manage pediatric acquired demyelinating syndromes.
- Enhanced understanding supports improved patient outcomes and prognosis.
- Ongoing research and clinical trials are vital for advancing treatment options.
Purpose Of Review:
This review summarizes a general approach to pediatric demyelination as well as specific features of each of the acquired demyelinating syndromes to help clinicians in their evaluation of children with these disorders. Case studies are included to illustrate the expanding phenotype of many of these syndromes.
Recent Findings:
With the creation of consensus definitions for the pediatric acquired demyelinating syndromes, recognition of demyelination in children has increased, as has understanding of the clinical and radiologic features, prognosis, and response to treatment. Collaborative studies and multicenter clinical trials are ongoing and needed to appropriately evaluate emerging therapies for some of the chronic demyelinating disorders, such as multiple sclerosis and neuromyelitis optica (NMO) spectrum disorder.
Summary:
This review will aid the clinician in identifying key features of the pediatric acquired demyelinating syndromes and highlights a general approach for the diagnosis and treatment of these disorders.
More Related Videos
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
04:55A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
Published on: May 11, 2022
Related Concept Videos
Nervous Tissue: Myelin
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Diphtheria
Pharmacokinetics in Pediatric Patients: Drug Excretion
Neurogenesis and Regeneration of Nervous Tissue